Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database

Watkins Paul B.; Lewis James H.; Kaplowitz Neil; Alpers David H.; Blais Jaime D.; Smotzer Dan M.; Krasa Holly; Ouyang John; Torres Vicente E.; Czerwiec Frank S.; Zimmer Christopher A.

首页> 外文期刊>Drug safety: An international journal of medical toxicology and drug experience >Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database

【24h】

Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database

机译：托伐普坦相关性肝损伤在常染色体显性多囊肾疾病患者中的临床表现：临床试验数据库分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Subjects with autosomal dominant polycystic kidney disease (ADPKD) who were taking tolvaptan experienced aminotransferase elevations more frequently than those on placebo in the TEMPO 3:4 (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) clinical trial.

机译：服用托伐普坦的常染色体显性遗传性多囊肾病（ADPKD）受试者在TEMPO 3：4（常染色体显性多囊性肾脏疾病及其结果管理中的托伐普坦功效和安全性）临床试验中经历的氨基转移酶升高频率高于安慰剂。

著录项

来源
《Drug safety: An international journal of medical toxicology and drug experience》 |2015年第11期|共11页
作者
Watkins Paul B.; Lewis James H.; Kaplowitz Neil; Alpers David H.; Blais Jaime D.; Smotzer Dan M.; Krasa Holly; Ouyang John; Torres Vicente E.; Czerwiec Frank S.; Zimmer Christopher A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药品;
关键词

相似文献

外文文献
中文文献
专利

1. Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database [J] . Watkins Paul B., Lewis James H., Kaplowitz Neil, Drug safety: An international journal of medical toxicology and drug experience . 2015,第11期

机译：托伐普坦相关性肝损伤在常染色体显性多囊肾疾病患者中的临床表现：临床试验数据库分析
2. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease. [J] . Hoevenaren IA, Wester R, Schrier RW, Liver international : . 2008,第2期

机译：多囊肝：与多囊肝和常染色体显性多囊肾疾病相比，孤立多囊肝病患者的临床特征。
3. Addressing the Need for Clinical Trial End Points in Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC) [J] . Smith Kimberly A., Thompson Aliza M., Baron David A., American Journal of Kidney Diseases: The official journal of the National Kidney Foundation . 2019,第4期

机译：解决常染色体显性多囊肾病中临床试验端点的需要：来自多囊肾疾病的报告结果结社（PKDOC）
4. Detection and Segmentation of Kidneys from Magnetic Resonance Images in Patients with Autosomal Dominant Polycystic Kidney Disease [C] . Antonio Brunetti, Giacomo Donato Cascarano, Irio De Feudis, International conference on intelligent computing . 2019

机译：常染色体显性多囊性肾脏病患者的磁共振图像肾脏检测与分割
5. Kidney segmentat ion and image analysis in autosomal dominant polycystic kidney disease [D] . Warner, Joshua Dale. 2016

机译：常染色体显性遗传性多囊性肾脏疾病的肾脏分割和图像分析
6. Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database [O] . Paul B. Watkins, James H. Lewis, Neil Kaplowitz, -1

机译：托伐普坦相关性肝损伤在常染色体显性多囊肾疾病患者中的临床模式：临床试验数据库分析
7. Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database [O] . 2015

机译：托伐普坦相关性肝损伤在常染色体显性多囊肾疾病患者中的临床模式：临床试验数据库分析

Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database

摘要

著录项

相似文献

相关主题

期刊订阅